Login about (844) 217-0978

Lisa Gilliland

In the United States, there are 193 individuals named Lisa Gilliland spread across 44 states, with the largest populations residing in Texas, Ohio, California. These Lisa Gilliland range in age from 51 to 63 years old. Some potential relatives include Kimberly Conner, Scott Gilliland, Linda Gilliland. You can reach Lisa Gilliland through various email addresses, including jeffery.spe***@centurytel.net, pgillil***@insightbb.com, alishamg***@gmail.com. The associated phone number is 251-633-8539, along with 6 other potential numbers in the area codes corresponding to 412, 507, 701. For a comprehensive view, you can access contact details, phone numbers, addresses, emails, social media profiles, arrest records, photos, videos, public records, business records, resumes, CVs, work history, and related names to ensure you have all the information you need.

Public information about Lisa Gilliland

Resumes

Resumes

Chemicical Dependecy Councelor

Lisa Gilliland Photo 1
Work:
Queen Treatment Center
Chemicical Dependecy Councelor

Lisa Overley Gilliland

Lisa Gilliland Photo 2
Location:
Saint Marys, OH
Industry:
Environmental Services
Work:
Celina Pet Center Jun 1994 - Jun 2005
Pet Stylist Jtdmh Jun 1994 - Jun 2005
Housekeeper
Education:
Memorial High School 1978 - 1981
Apollo Adult Learning Center
Skills:
Photoshop, Sales

Director Of Sales At Universal Display & Design Inc.

Lisa Gilliland Photo 3
Position:
Director of Sales at Universal Display & Design
Location:
Greater New York City Area
Industry:
Marketing and Advertising
Work:
Universal Display & Design - New York, New York since Nov 2012
Director of Sales LG&P In-store Agency Jun 2010 - Nov 2012
Account Director American Standard Jun 2007 - Jun 2010
Account Manager UBS Dec 2000 - Jul 2003
Sales & Marketing Associate
Education:
Northeastern University 2004 - 2007
BS, Criminal Justice, Political Science
Skills:
National Account Management, New Business Development, Marketing Strategy, Merchandising Strategies, POG Management, Global Logistics, Management, Retail, Account Management, Merchandising, Product Development, Brand Management, Product Marketing, Cross-functional Team Leadership, Marketing, Strategy
Interests:
Leadership Management Economics Innovati... Strategy Travel Running
Honor & Awards:
Summa Cum Laude

National Account Manager

Lisa Gilliland Photo 4
Location:
Charlotte, NC
Work:
The Hillman Group
National Account Manager
Education:
Northeastern University Jan 1, 2004 - Dec 31, 2007
Interests:
Leadership
Innovation
Management
Economics
Running
Strategy
Travel

Teacher

Lisa Gilliland Photo 5
Location:
P/O Box 72, Mathiston, MS
Industry:
Music
Work:
Webster County School District
Teacher

Senior Sales Coordinator

Lisa Gilliland Photo 6
Location:
Brandon, MS
Industry:
Chemicals
Work:
Ep Engineered Clays Corporation
Senior Sales Coordinator Engelhard Corporation Oct 1996 - Jun 2006
Inside Sales Basf Oct 1996 - Jun 2006
Supply Chain Planner
Education:
University of Central Oklahoma 1987 - 1991
Bachelors, Advertising Edmond Memorial High School 1987
Durant High School 1987
Skills:
Supply Chain, Management, Supply Chain Management, Sap, Logistics, Continuous Improvement, Six Sigma, Manufacturing, Forecasting, Negotiation, Supply Chain Optimization, Customer Service, New Business Development, Team Building, Business Development
Certifications:
Cpim
Apics

Freelance Blogger

Lisa Gilliland Photo 7
Location:
Rome, GA
Work:
Atoninggrace
Freelance Blogger
Education:
Georgia Northwestern Technical College 2012 - 2014

Lisa Gilliland

Lisa Gilliland Photo 8
Location:
1625 Pinedale Ln, Chesapeake, VA 23322
Industry:
Financial Services
Work:
Capital One May 2012 - May 2013
Unit Manager Hsbc Feb 2005 - May 2012
Unit Manager Metris Companies Jan 2001 - Feb 2005
Unit Manager
Education:
University of Central Oklahoma 1987 - 1989
Bachelors, Education University of Central Oklahoma
Bachelors, Bachelor of Arts
Skills:
Call Centers, Customer Service, Management, Credit Cards, Leadership, Financial Services, Coaching, Team Leadership, Risk Management, Process Improvement, Business Analysis, Team Building, Operations Management, Customer Experience, Performance Management, Business Process Improvement, Banking, People Management, Change Management, Training, Customer Experience Management, Credit, Contact Centers, Loans, Relationship Management, Mortgage Lending, Retail Banking, Vendor Management
Sponsored by TruthFinder

Phones & Addresses

Name
Addresses
Phones
Lisa A Gilliland
814-786-8072
Lisa A Gilliland
281-488-3161
Lisa Gilliland
251-633-8539
Lisa C Gilliland
970-416-1498
Lisa Gilliland
412-415-3565
Lisa C Gilliland
828-396-3955
Lisa C Gilliland
956-425-5290
Lisa Gilliland
334-567-2829
Lisa Gilliland
205-302-0543
Lisa Gilliland
662-343-5644
Lisa Gilliland
740-649-5914
Lisa Gilliland
715-359-7443
Lisa Gilliland
334-220-5246

Publications

Us Patents

Monoclonal Antibodies And Fv Specific For Cd2 Antigen

US Patent:
5807734, Sep 15, 1998
Filed:
May 31, 1995
Appl. No.:
8/456221
Inventors:
Michael L. Diegel - Kent WA
Peter S. Linsley - Seattle WA
Lisa K. Gilliland - Seattle WA
Patricia A. Moran - Seattle WA
Joyce M. Zarling - Seattle WA
Jeffrey A. Ledbetter - Seattle WA
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07H 2104
C12N 1511
C12N 120
C12N 121
US Classification:
43525233
Abstract:
An anti-CD2 monoclonal antibody according to the present invention can be: (1) a chimeric monoclonal antibody CD2 SFv-Ig produced by expression of the construct cloned in recombinant Escherichia coli culture ATCC No. 69277; (2) a monoclonal antibody having complementarity-determining regions identical with those of CD2 SFv-Ig; or (3) a monoclonal antibody competing with CD2 SFv-Ig for binding to CD2 antigen at least about 80% as effectively on a molar basis as CD2 SFv-Ig. Anti-CD2 monoclonal antibodies according to the present invention, as well as other antibodies that can modulate the interactions between T lymphocytes and monocytes, can be used to inhibit the production of HIV-1 by HIV-1-infected T cells in HIV-1-infected patients. In another use, T cells treated in vitro can be reinfused into AIDS patients to increase the proportion of functional, non-HIV-1-producing T cells in the patient.

Monoclonal Antibodies And Fv Specific For Cd2 Antigen

US Patent:
5795572, Aug 18, 1998
Filed:
May 25, 1993
Appl. No.:
8/068946
Inventors:
Michael L. Diegel - Kent WA
Peter S. Linsley - Seattle WA
Lisa K. Gilliland - Seattle WA
Patricia A. Moran - Seattle WA
Joyce M. Zarling - Seattle WA
Jeffrey A. Ledbetter - Seattle WA
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07K 1628
A61K 39395
A61K 3944
G01N 3353
US Classification:
4241351
Abstract:
An anti-CD2 monoclonal antibody according to the present invention can be: (1) a chimeric monoclonal antibody CD2 SFv-Ig produced by expression of the construct cloned in recombinant Escherichia coli culture ATCC No. 69277; (2) a monoclonal antibody having complementarity-determining regions identical with those of CD2 SFv-Ig; or (3) a monoclonal antibody competing with CD2 SFv-Ig for binding to CD2 antigen at least about 80% as effectively on a molar basis as CD2 SFv-Ig. Anti-CD2 monoclonal antibodies according to the present invention, as well as other antibodies that can modulate the interactions between T lymphocytes and monocytes, can be used to inhibit the production of HIV-1 by HIV-1-infected T cells in HIV-1-infected patients. In another use, T cells treated in vitro can be reinfused into AIDS patients to increase the proportion of functional, non-HIV-1-producing T cells in the patient.

Methods For Inhibiting The Production Of Hiv-1 Retrovirus Using Monoclonal Antibodies And Fv Specific For Cd2 Antigen

US Patent:
6384198, May 7, 2002
Filed:
May 31, 1995
Appl. No.:
08/443888
Inventors:
Michael L Diegel - Kent WA
Peter S Linsley - Seattle WA
Lisa K Gilliland - Seattle WA
Patricia A Moran - Seattle WA
Joyce M Zarling - Seattle WA
Jeffrey A Ledbetter - Seattle WA
Assignee:
Bristol-Myers Sqibb Company - Princeton NJ
International Classification:
C07K 1628
US Classification:
5303901, 435 2, 5303871, 5303873, 5303881, 5303882, 53038822, 5303887, 53038873, 53038875
Abstract:
An anti-CD2 monoclonal antibody according to the present invention can be: (1) a chimeric nonclonal antibody CD2 SFv-Ig produced by expression of the construct cloned in recombinant culture ATCC No. 69277; (2) a monoclonal antibody having complementarity-determining regions identical with those of CD2 SFv-Ig; or (3) a monoclonal antibody competing with CD2 SFv-Ig for binding to CD2 antigen at least about 80% as effectively on a molar basis as CD2 SFv-Ig. Anti-CD2 monoclonal antibodies according to the present invention, as well as other antibodies that can modulate the interactions between T lymphocytes and monocytes, can be used to inhibit the production of HIV-1 by HIV-1-infected T cells in HIV-1-infected patients. In another use, T cells treated in vitro can be reinfused into AIDS patients to increase the proportion of functional non-HIV-1-producing T cells in the patient.

Therapeutic Antibodies With Reduced Side Effect

US Patent:
2013002, Jan 31, 2013
Filed:
Aug 19, 2011
Appl. No.:
13/199127
Inventors:
Herman Waldmann - Oxford, GB
Mark Raymond Frewin - Eltham North, AU
Lisa Kim Gilliland - Atwater CA, US
Luis Ricardo Simoes DaSilva Graca - Oxford, GB
International Classification:
A61K 39/395
US Classification:
4241341, 4241781
Abstract:
A therapeutic protein, such as a therapeutic antibody, that is modified with a compound that inhibits binding of the protein to its therapeutic target, thereby reducing side effects caused by the protein.

Therapeutic Antibodies With Reduced Side Effect

US Patent:
2004010, Jun 10, 2004
Filed:
Jul 9, 2003
Appl. No.:
10/615718
Inventors:
Herman Waldmann - Oxford, GB
Mark Frewin - Oxford, GB
Lisa Gilliland - Merced CA, US
Luis Simoes Da Silva Graca - Oxford, GB
International Classification:
A61K039/395
A61K038/17
US Classification:
424/130100, 514/012000
Abstract:
A therapeutic protein, such as a therapeutic antibody, that is modified with a compound that inhibits binding of the protein to its therapeutic target, thereby reducing side effects caused by the protein.

Antibody Heteroconjugates And Bispecific Antibodies For Use In Regulation Of Lymphocyte Activity

US Patent:
6010902, Jan 4, 2000
Filed:
Dec 29, 1994
Appl. No.:
8/366401
Inventors:
Jeffrey A. Ledbetter - Seattle WA
Lisa K. Gilliland - Seattle WA
Assignee:
Bristol-Meyers Squibb Company - Princeton NJ
International Classification:
C12N 500
C12N 502
C07K 1600
C12P 2108
US Classification:
435328
Abstract:
The present invention relates to novel antibody heteroconjugates and bispecific antibodies and methods and compositions and their use in the enhancement or inhibition of activation and function of T or B lymphocytes. The heteroconjugates are comprised of at least two antibody molecules cross-linked to each other, each molecule being reactive with a different lymphocyte antigen on the same cell. The invention also provides bispecific antibodies comprising a first binding region reactive with an antigen on a lymphocyte and a second binding region reactive with a different antigen on the lymphocyte. The heteroconjugates, bispecific antibodies, methods and compositions of this invention are therefore useful in the regulation of lymphocyte function, resulting in the improvement of cellular immune responses in various disease states.

Expression Vectors Encoding Bispecific Fusion Proteins And Methods Of Producing Biologically Active Bispecific Fusion Proteins In A Mammalian Cell

US Patent:
6132992, Oct 17, 2000
Filed:
Oct 5, 1995
Appl. No.:
8/539436
Inventors:
Jeffrey A. Ledbetter - Seattle WA
Lisa K. Gilliland - Seattle WA
Martha S. Hayden - San Diego CA
Peter S. Linsley - Seattle WA
Jurgen Bajorath - Everett WA
H. Perry Fell - Redmond WA
Assignee:
Bristol-Myers Squibb Co. - New York NY
International Classification:
C12P 2102
C12N 1585
C07K 1628
US Classification:
435 697
Abstract:
The present invention provides an expression vector encoding monospecific or bispecific fusion protein. In one embodiment the expression vector encodes a monospecific fusion protein, which vector comprises a recombinant monospecific single chain cassette comprising a DNA sequence encoding a first binding domain capable of binding a cell surface antigen. In another embodiment the expression vector encodes a bispecific fusion protein, which vector comprises a recombinant bispecific single chain cassette comprising a DNA sequence encoding a first binding domain capable of binding a cell surface antigen and a DNA sequence encoding a second binding domain capable of binding a cell surface antigen, each domain capable of binding a different antigen. The present invention also provides a method for producing a biologically active monospecific or bispecific fusion protein in a mammalian cell. This method comprises: (a) transfecting the mammalian cell with the recombinant expression vector of the invention; (b) culturing the mammalian cell so transfected in step (a); and (c) recovering the biologically active bispecific fusion protein so as produced by the cultured mammalian cell.

Expression Vectors Encoding Bispecific Fusion Proteins And Methods Of Producing Biologically Active Bispecific Fusion Proteins In A Mammalian Cell

US Patent:
5637481, Jun 10, 1997
Filed:
Sep 13, 1993
Appl. No.:
8/121054
Inventors:
Jeffrey A. Ledbetter - Seattle WA
Lisa K. Gilliland - Seattle WA
Martha S. Hayden - San Diego CA
Peter S. Linsley - Seattle WA
Jurgen Bajorath - Everett WA
H. Perry Fell - Redmond WA
Assignee:
Bristol-Myers Squibb Company - New York NY
International Classification:
C12N 1579
C12N 510
C12P 2100
US Classification:
435 696
Abstract:
The present invention provides an expression vector encoding monospecific or bispecific fusion protein. In one embodiment the expression vector encodes a monospecific fusion protein, which vector comprises a recombinant monospecific single chain cassette comprising a DNA sequence encoding a first binding domain capable of binding a cell surface antigen.

FAQ: Learn more about Lisa Gilliland

What is Lisa Gilliland's email?

Lisa Gilliland has such email addresses: jeffery.spe***@centurytel.net, pgillil***@insightbb.com, alishamg***@gmail.com, harley33***@adelphia.net, lisa.s.gillil***@gmail.com, lisa.gillil***@att.net. Note that the accuracy of these emails may vary and they are subject to privacy laws and restrictions.

What is Lisa Gilliland's telephone number?

Lisa Gilliland's known telephone numbers are: 251-633-8539, 412-415-3565, 507-845-2490, 701-968-3886, 704-951-8030, 785-690-7318. However, these numbers are subject to change and privacy restrictions.

How is Lisa Gilliland also known?

Lisa Gilliland is also known as: Lisa D, Lisa L Krebs, Lisa L Gilliand, Betty M Krebs. These names can be aliases, nicknames, or other names they have used.

Who is Lisa Gilliland related to?

Known relatives of Lisa Gilliland are: Michelle Mcfarland, Kay Garrett, Frances Coker, Julie Coker, Michael Coker, Ann Stathakis. This information is based on available public records.

What are Lisa Gilliland's alternative names?

Known alternative names for Lisa Gilliland are: Michelle Mcfarland, Kay Garrett, Frances Coker, Julie Coker, Michael Coker, Ann Stathakis. These can be aliases, maiden names, or nicknames.

What is Lisa Gilliland's current residential address?

Lisa Gilliland's current known residential address is: 5010 W Tether Trl, Phoenix, AZ 85083. Please note this is subject to privacy laws and may not be current.

What are the previous addresses of Lisa Gilliland?

Previous addresses associated with Lisa Gilliland include: 1178 Plaza, Joppa, MD 21085; 3302 Samuel, Saint Paul, MN 55127; 3340 Dodd, Saint Paul, MN 55121; 40020 Chaffin, Hamilton, MS 39746; 404 8Th, Cando, ND 58324. Remember that this information might not be complete or up-to-date.

Where does Lisa Gilliland live?

Phoenix, AZ is the place where Lisa Gilliland currently lives.

How old is Lisa Gilliland?

Lisa Gilliland is 53 years old.

What is Lisa Gilliland date of birth?

Lisa Gilliland was born on 1971.

People Directory:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z